1Noguchi M,Koyasaki N,Ohta N,et al.C-erb B-2 oncoprotein expression veraus internal mammary lyntph node rnetastases as additional prohnostic factors in patients with axillary lymob node-positive breast cencer.Cancer,1992:69(13):2953.
2Berchuck A,Kamel A,Whitaker R,et al.Overexpression of Her-2/new is associated with poor survival in sdvanced epithelial ovarian cancer.Cancer Ressarch,1990:50(13):4087.
3Allred DC,Clark GM,Molina R,et al.Overexpression of Her-2/new and its relaoonship with other prognostic factors change during the progreassionof i situ to srvasive breast-cascer.Human Pathology,1992:23(9):974.
4Porter Pl.Garcia R,Moe R,et al.C-reb B-2 oncogenc protein i situ and invasive lobular breast neoplasis.Cancer,1991:68(2):331.
5Wright C,Nicholson S.Angus B,et al.Relationship C-erb B-2 pretein product expression and response to endoctine therapy in sdvanced breast cancer.British Journal of Cancer,1992:65(1):118.
6Vaughb JP,Stekler J,Demizdji S,et al.Inhibition of the C-erd B-2 tyrisne kinses receptor in breast cancer cells by phosporomonothioated and phosphorodithioate antisence oligonucleotides.Nucleic Acida Res,1996:24(3):4558.
7Visscher DW,Wallis T,Awussah S,et al.Evalustion of myc and chromosome δcopy number in breast carcinoma by interhpase cytogenetics .Egenes Cgromcsomes Cancer,1997:18(1):1.
8Lindiom A,Skoog L,Rotstcin S,et al.Lcros of Hetenxygosity in [] breest carcinomas carninogenesis.Cancer Research,1993:53(18):4356.
9Alan H,Signal transduction through small GTP ases-a tale of two GAPs.Call .1992:69(3):389.
10Weindery RA.Oncogeaes,antioncogenes,and the moleeular bases of multistep.Cancer Research.1989:49(11):3713.
